Your session is about to expire
← Back to Search
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery (TPVB Trial)
TPVB Trial Summary
This trial will compare single-injection vs multiple injections of thoracic paravertebral block for anesthesia during breast cancer surgery. It may reduce post-op nausea, narcotic use and hospital stay, and improve patient satisfaction.
TPVB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TPVB Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an infection where I would get injections.I have moderate to severe obstructive sleep apnea.I have chosen not to participate in this trial.My body weight is under 50 kg.I cannot communicate with the research team.My kidney function is very low.I have been using opioids daily for chronic pain for the last 3 months.I am over 18, have an ASA status of I-III, a BMI under 35, and am getting a mastectomy without lymph node removal.I have a serious heart condition.I am on blood thinners or have a bleeding disorder.I am under 18 years old.My liver is not working properly.
- Group 1: Thoracic paravertebral block multiple (3) injections
- Group 2: Thoracic paravertebral block single injection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still open for this clinical trial?
"Affirmative. The clinicaltrials.gov database indicates that this medical experiment, which was initially published on November 4th 2022, is presently enlisting volunteers. Approximately 68 patients must be recruited from 1 different healthcare facility."
How many participants are eligible for enrollment in this trial?
"Affirmative, the clinicaltrials.gov entry for this trial confirms it is currently enrolling participants. This research project was initially listed on November 4th 2022 and last modified on February 1st 2023. Sixty-eight patients are required to join from a single medical facility."
Which results is this trial attempting to achieve?
"This trial aims to assess total amount of ketamine used during the intraoperative period, which is about 30 minutes. Secondary objectives include evaluating adverse effects such as hypotension and vagal reaction; pre-surgical block levels with an ice test after 20 minutes post-block; and postoperative pain at rest and on movement (VAS) in PACU or day surgery unit every 15 minutes until discharge."
Share this study with friends
Copy Link
Messenger